Icahn School of Medicine at Mount Sinaï — New York, New York

Icahn School of Medicine at Mount Sinaï is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Icahn School of Medicine at Mount Sinaï has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Head and Neck Neoplasms, Ventricular Arrythmia.

Sponsors: Innate Pharma, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icahn School of Medicine at Mount Sinaï?

Icahn School of Medicine at Mount Sinaï has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icahn School of Medicine at Mount Sinaï conducted?

Icahn School of Medicine at Mount Sinaï has 2 clinical trials on record, with 1 currently active. Their work covers Head and Neck Neoplasms, Ventricular Arrythmia.

Is Icahn School of Medicine at Mount Sinaï accredited by Crixeo Health?

Icahn School of Medicine at Mount Sinaï has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Icahn School of Medicine at Mount Sinaï?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.